{"disease":{"id":"extrahepatic-cholangiocarcinoma","name":"extrahepatic cholangiocarcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07176962","title":"A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening","phase":"","overall_status":"RECRUITING","enrollment_count":1800,"lead_sponsor_name":"Yingbin Liu, MD, PhD, FACS","has_results":false},{"nct_id":"NCT04596865","title":"Recurrence After Whipple's (RAW) Study","phase":"","overall_status":"COMPLETED","enrollment_count":1484,"lead_sponsor_name":"University Hospital Plymouth NHS Trust","has_results":false},{"nct_id":"NCT02834013","title":"Nivolumab and Ipilimumab in Treating Patients With Rare Tumors","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":818,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT05896956","title":"The Construction of Clinical Database and Multiomics Biobank Based on a Multicentral Prospective Cohort of Benign and Malignant Biliary Tract Diseases","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT03768414","title":"Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":452,"lead_sponsor_name":"SWOG Cancer Research Network","has_results":true},{"nct_id":"NCT06101277","title":"Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)","phase":"NA","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"University of California, Davis","has_results":false},{"nct_id":"NCT07454486","title":"TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cancer: a Real- World Cohort","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Aarhus University Hospital","has_results":false},{"nct_id":"NCT07007832","title":"Bile Omics for Diagnosing Indeterminate Biliary Strictures","phase":"","overall_status":"RECRUITING","enrollment_count":260,"lead_sponsor_name":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT05233293","title":"Spyglass+RFA Versus Cytobrush+RFA for Extrahepatic Cholangiocarcinoma","phase":"NA","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"First People's Hospital of Hangzhou","has_results":false},{"nct_id":"NCT06923475","title":"Neoadjuvant Gemcitabine and Cisplatin in Combination With Perioperative Pembrolizumab Versus Upfront Surgery for Patients With Primary Resectable and Borderline Resectable Perihilar and Distal Cholangiocarcinoma","phase":"PHASE2, PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Amsterdam UMC, location VUmc","has_results":false},{"nct_id":"NCT07235007","title":"Repeated Endobiliary Radiofrequency Ablation Plus Durvalumab, Gemcitabine, and Cisplatin for Unresectable Extrahepatic Cholangiocarcinoma","phase":"NA","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Aichi Medical University","has_results":false},{"nct_id":"NCT05519319","title":"Safety and Efficacy of PDT vs RFA vs PDT+RFA for the Treatment of Extrahepatic Cholangiocarcinoma","phase":"NA","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"First People's Hospital of Hangzhou","has_results":false},{"nct_id":"NCT03377179","title":"A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced Cholangiocarcinoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"RedHill Biopharma Limited","has_results":false},{"nct_id":"NCT05251233","title":"Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":56,"lead_sponsor_name":"Washington University School of Medicine","has_results":true},{"nct_id":"NCT03257761","title":"Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":55,"lead_sponsor_name":"University of Southern California","has_results":false},{"nct_id":"NCT06901622","title":"Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic Cholangiocarcinoma","phase":"PHASE2","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":50,"lead_sponsor_name":"The First Affiliated Hospital of Zhengzhou University","has_results":false},{"nct_id":"NCT05448183","title":"An Observational Real World Study on the Efficacy and Safety of Toripalimab Injection Combined With TACE in the Treatment of Extrahepatic Cholangiocarcinoma","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":45,"lead_sponsor_name":"Xuhua Duan","has_results":false},{"nct_id":"NCT06964425","title":"Raman Spectroscopy in the Diagnosis of Extrahepatic Cholangiocarcinoma - a Pilot Study","phase":"NA","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"University Hospital Olomouc","has_results":false},{"nct_id":"NCT05009953","title":"Study of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract Cancer","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":17,"lead_sponsor_name":"CSPC Ouyi Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT04561453","title":"Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer","phase":"","overall_status":"TERMINATED","enrollment_count":14,"lead_sponsor_name":"University of Washington","has_results":false},{"nct_id":"NCT03414489","title":"Expanded Access for the Treatment of Advanced Cholangiocarcinoma With ABC294640 (Yeliva ®)","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"RedHill Biopharma Limited","has_results":false}],"total":21},"guidelines":[],"source":"Drug Landscape verified database"}